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Abstract The nuclear lamina protein, lamin A is produced by
proteolytic cleavage of a 74 kDa precursor protein, prelamin A.
The conversion of this precursor to mature lamin A is mediated
by a specific endoprotease, prelamin A endoprotease. Subnuclear
fractionation indicates that the prelamin A endoprotease is
localized at the nuclear membrane. The enzyme appears to be an
integral membrane protein, as it can only be removed from the
nuclear envelope with detergent. It is effectively solubilized by
the detergent n-octyl-L-D-glucopyranoside and can be partially-
purified (V1200-fold) by size exclusion and cation exchange
(Mono S) chromatography. Prelamin A endoprotease from
HeLa cells was eluted from Mono S with 0.3 M sodium chloride
as a single peak of activity. SDS-PAGE analysis of this prelamin
A endoprotease preparation shows that it contains one major
polypeptide at 65 kDa and smaller amounts of a second 68 kDa
polypeptide. Inhibition of the enzyme activity in this preparation
by specific serine protease inhibitors is consistent with the
enzyme being a serine protease.
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1. Introduction
Proteins which carry a CAAX (X = methionine, serine, ala-
nine) consensus sequence at their carboxy-terminus are sub-
strates for farnesylation, a 15-carbon isoprenoid, modi¢ca-
tion, followed by endoproteolytic removal of the AAX
tripeptide and carboxyl methylation of the now terminal cys-
teine [1^5]. Farnesyl modi¢cation of proteins is of interest due
to its role in the function of a number of growth regulatory
proteins, including ras-oncogene products [6], two of the
structural proteins of nuclear lamina, prelamin A, a precursor
protein for lamin A [7] and lamin B [8], cyclic GMP phos-
phodiesterase K, rhodopsin kinase and Q-transducin [9]. These
post-translational modi¢cations apparently act, in concert
with other structural features of the modi¢ed proteins, to
promote targeting of these proteins to speci¢c cellular com-
partments. Uniquely, prelamin A undergoes a second endo-
proteolytic cleavage following the post-translational modi¢ca-
tions [10^13]. Despite the loss of the carboxy-terminal 18
amino acids, prelamin A nevertheless undergoes all of the
reactions characteristic of other CAAX proteins [14]. We
have previously shown that farnesylation-dependent removal
of the 18 carboxy-terminal amino acids is a requirement for
assembly of lamin A into the nuclear lamina [7]. In the ab-
sence of this cleavage, prelamin A can neither give rise to
lamin A nor assemble into the nuclear lamina [15]. We call
this enzyme, which speci¢cally cleaves the farnesylated car-
boxy-methylated precursor, the ‘prelamin A endoprotease.’
Based on a comparison of the predicted sequence for hu-
man prelamin A from its cDNA and direct sequencing of the
carboxy-terminus of the mature lamin A molecule, this second
endoproteolysis occurs between a tyrosine (Y657) and a leucine
(L658) 18 amino acid residues upstream from the carboxy-ter-
minus of the prelamin A molecule [11]. Also, searches of pro-
tein sequence data bases revealed that the RSY657L658LG se-
quence in the prelamin A molecule which contains the
carboxy-terminus of mature lamin A, is unique and highly
conserved between species. Recently, we demonstrated
[14,16] that this simple hexapeptide is a substrate for the prel-
amin A endoprotease, con¢rming its functional signi¢cance in
conferring speci¢city. We have also presented some evidence
suggesting that the prelamin A endoprotease has prelamin A
as its only substrate. Prelamin A is the only nuclear protein
that undergoes prenylation-dependent endoproteolysis. Fur-
thermore, we have shown that the activity of prelamin A
endoprotease is signi¢cantly higher in cells that express prel-
amin A compared to those that do not [16]. In this context, it
becomes of interest to determine whether the nucleus is the
only cellular compartment in which this endoproteolytic ac-
tivity resides. Detection of this activity in cytosolic and nu-
clear preparations would suggest that there might be multiple
substrates for prelamin A endoprotease. However, if the nu-
cleus is the only cellular compartment for this activity, this
would be consistent with the hypothesis that prelamin A is the
only substrate for this endoprotease.
Here, we initiate the puri¢cation of prelamin A endopro-
tease by subcellular fractionation, thereby localizing it to the
nuclear envelope. This observation is consistent with prelamin
A being a unique substrate for the prelamin A endoprotease.
The activity of this membrane enzyme is successfully solubi-
lized in detergent n-octyl-L-D-glucopyranoside (octyl gluco-
side) and partially-puri¢ed.
2. Materials and methods
2.1. Subfractionation of HeLa nuclei
HeLa cells were cultured in Ham’s F12 medium supplemented with
10% fetal calf serum (v/v) (FCS), 100 U/ml penicillin, 100 Wg/ml
streptomycin and 1 Wg/ml amphotericin B.
Cells were washed several times with phosphate-bu¡ered saline
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(PBS), harvested from culture dishes by trypsinization and pelleted by
centrifugation in an IEC clinical centrifuge (Damon/IEC, Needham
Heights, MA, USA) for 10 minute at 140Ug and then resuspended in
¢ve volumes of PBS. Resuspended, washed cells (2U108/ml) were
lysed (500 psi for 10 s) with a nitrogen cavitation bomb (Kontes Glass
Company, Millville, NJ, USA). Large particulate material, including
nuclei, was collected by centrifugation (900Ug, 10 min) and retained
for preparation of the nuclear extract. The post-nuclear supernatant
was also assayed for activity. All fractionation steps were carried out
at room temperature.
The crude nuclei were resuspended in 10 ml TEA bu¡er (20 mM
triethanol amine-HCl, pH 7.5, 1 mM DTT, 0.1 mM MgCl2, 2 Wg/ml
DNase, 250 ng/ml RNase) and incubated on ice for 15 min. Nuclear
envelopes were prepared by a modi¢cation [13] of the procedure of
Dwyer and Blobel [17]. The nuclear envelope fraction was treated with
3% octyl glucoside to solubilize the enzyme. Except for the puri¢ed
enzyme, protein concentrations were measured using the Micro BCA
Protein Assay Reagent kit (Pierce Chemical, Rockford, IL, USA).
2.2. Assay for the activity of prelamin A endoprotease
This assay was performed as previously described [10,12]. Brie£y,
the endoprotease reaction was initiated by the addition of
[125I]RSY*LLG to the cell fractions in a ¢nal volume of 20 Wl in
enzyme assay bu¡er (10 mM MES, pH 5.0). After 20 min at 37‡C,
the reaction was stopped by the addition of 5 Wl of glacial acetic acid
and chilling on ice for 10 min. The reaction mixture was applied to
reverse phase thin layer chromatography (TLC) plates (Analtech,
Newark, DE, USA), which were developed with 10% acetonitrile in
water. The product spots were visualized by autoradiography. The
identity of the reaction product was con¢rmed by its co-migration
with a synthetic, iodinated RSY* peptide standard. Amounts of la-
belled RSY formed were determined by scraping the appropriate spots
into tubes and quantitation of radioactivity with a gamma counter.
2.3. Puri¢cation of prelamin A endoprotease
Nuclear envelope extract from V1010 HeLa cells was concentrated
approximately 4-fold by an Amicon CentriPrep-10 concentrator. One-
half of the concentrated nuclear envelope extract (a volume of 200 Wl)
was loaded onto a Sephacryl S-200-HR (1U60 cm) column (Pharma-
cia Fine Chemicals) that had been equilibrated in 10 mM MES, pH
5.5, containing 0.1% octyl glucoside. Under these conditions, blue
dextran eluted at 60 min indicating a void volume of 15 ml. The
£ow rate was 0.25 ml/min and the material eluting after the void
volume was collected in 0.5 ml fractions. Column calibration was
based on the size standards IgG, albumin, trypsinogen and cyto-
chrome c.
The enzymatically active fractions from the gel ¢ltration column
(70^82) were pooled and concentrated approximately 2-fold by an
Amicon CentriPrep-10 concentrator prior to loading on a Mono S
(HR 5/5 cation exchange) column (Pharmacia Fine Chemicals). The
Mono S column was equilibrated with 10 mM MES, pH 5.5, contain-
ing 0.1% octyl glucoside and 0.2% NaN3. The £ow rate was main-
tained at 0.75 ml/min during loading and graident elution. After load-
ing the sample, the column was washed with equilibration bu¡er for
10 min, followed by development with a 30 min linear gradient from
0 to 0.6 M NaCl in the equilibration bu¡er. The column was then
washed with bu¡er containing 1 M NaCl for 10 min and re-equili-
brated for 20 min. Fractions were collected at 1 min intervals for the
entire 70 min elution program. The active fractions from Mono S run
were pooled and stored at 380‡C.
Chromatographic procedures were performed with an intermediate
pressure protein liquid chromatography system (Waters 625LC sys-
tem). SDS-PAGE was carried out as described by Laemmli [18] and
the gels were calibrated with broad range SDS-PAGE standards (Life
Technology). The protein content of puri¢ed endoprotease was esti-
mated by Coomassie blue R-250 staining of a 10% SDS-PAGE in
which known amounts (0.1^0.5 Wg) of broad range (Life Technology)
SDS-PAGE standard proteins were used as a reference.
3. Results
3.1. Subcellular distribution of prelamin A endoprotease in
HeLa cells
In this study, the synthetic substrate, [125I]RSY*LLG
[14,16] was used to assay the prelamin A endoprotease. The
RSY* product was isolated by reverse phase TLC, visualized
by autoradiography and identi¢ed by co-migration with ra-
dio-iodinated RSY* synthetic peptide, as described before
[14].
Previous studies [15] from our laboratory and others [12] on
whole cells have established that endoproteolytic processing of
prelamin A takes place in the nucleus. Consistent with this
observation, no endoprotease activity was detected in post-
nuclear supernatants but was detected in crude nuclei (Fig.
1). Furthermore, the enzyme activity was enriched in the nu-
clear envelope relative to the nucleoplasm. These observations
are in agreement with the hypothesis that prelamin A endo-
protease is associated with nuclear envelopes.
3.2. Solubilization of endoprotease activity
Initial experiments were aimed at determining whether the
protease behaved as an integral membrane protein. The HeLa
nuclear envelope was resuspended in 10 mM MES bu¡er at
pH 5.0 with a hand-held homogenizer and incubated at 4‡C
for 45 min. The membranes were pelleted by centrifugation at
100 000Ug for 1.5 h. All of the original activity remained
associated with the pellets, which were then subjected to other
solubilzing agents.
Urea (4 M), which can solubilize the nuclear lamin proteins
[19], and a variety of detergents were tested. After extraction,
insoluble material was collected by ultracentrifugation and
both pellets and supernatant were assayed for the endopro-
tease activity. The supernatant from the 4 M urea treatment
was dialyzed against 10 mM MES and assayed but no appre-
ciable proteolytic activity was found in the supernatant. That
treatment with 4 M urea did not solubilize the enzyme activity
Fig. 1. Subcellular distribution of prelamin A endoprotease in HeLa
cells. The prelamin A endoprotease was assayed in various subcellu-
lar fractions and the RSY* formed followed by autoradiographic
visualization after reverse-phase TLC separation of the reaction
products. The speci¢c activity of prelamin A endoprotease is deter-
mined following the detection of the reaction product on the ¢lm.
The results are the average of three determinations. A typical radio-
chromatogram is shown. Lane 1, synthetic radio-iodinated RSY*;
lane 2, HeLa nuclear envelope extract; lane 3, nuclear envelope;
lane 4, nucleoplasm; lane 5, crude nuclei and lane 6, post-nuclear
supernatant are assayed for endoprotease activity by formation of
radio-iodinated RSY as described under Section 2. The radio-la-
belled material at the solvent front co-migrates with iodotyrosine.
There was 40 Wg protein used per assay.
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is consistent with the notion that prelamin A endoprotease
from the HeLa nuclear envelope is an integral membrane
protein rather than associated with the nuclear lamina. Con-
sistent with nuclear membrane association of the prelamin A
endoprotease, extraction with non-ionic detergents (NP-40 or
octyl glucoside), a treatment which is known to solubilize
nuclear membranes but leaves behind an insoluble nuclear
pore-lamina complex [10,17], substantially solubilized the en-
zyme and increased its speci¢c activity (Fig. 1).
For solubilization of activity for enzyme puri¢cation, we
chose to use octyl glucoside, as it e¡ectively released 90% of
the endoprotease activity from the nuclear envelope under
optimum conditions. Optimal solubilization was obtained at
3% octyl glucoside (Fig. 2). Moreover, octyl glucoside does
not interfere with the monitoring of columns at 280 nm.
By three criteria, the enzyme was successfully solubilized by
3% octyl glucoside: (a) After centrifugation at 100 000Ug for
1.5 h, the endoprotease activity was maintained in the super-
natant, (b) 100% of the octyl glucoside-solubilized endopro-
tease activity passed through a 0.22 Wm ¢lter (Millipore), (c)
after size exclusion chromatography of the nuclear envelope
extract, prelamin A endoprotease activity was detected be-
tween the void volume and the column volume.
3.3. Partial puri¢cation of prelamin A endoprotease
The solubilized HeLa nuclear envelope was chromato-
graphed on a Sephacryl S-200-HR column. Protein elution
was monitored at 280 nm and fractions were assayed for
activity. The major activity peak (Fig. 3A) corresponded to
a size of approximately 65 kDa. Most of the protein applied
was excluded from the column (data not shown). Peak activity
fractions were pooled and concentrated approximately 2-fold
by an Amicon CentriPrep-10 prior to chromatography on a
Mono S column. Fig. 3B shows the elution pro¢le of prelamin
A endoprotease from the ion exchange column. The majority
of the protein and approximately half of the activity did not
bind to this column. The activity retained on the column
(second peak) was eluted at approximately 0.3 M sodium
Fig. 2. Octyl glucoside solubilization of prelamin A endoprotease
activity. The HeLa nuclear envelope was suspended at 4‡C to 4 mg
of protein/ml in 10 mM MES, pH 5.0. 100 Wl sample in each tube
was mixed with 100 Wl of octyl glucoside solutions in the same bu¡-
er to give the ¢nal concentrations shown and the samples were kept
on ice for 30 min. After centrifugation at 100 000Ug for 1.5 h, the
supernatants were assayed for prelamin A endoprotease activity.
The results are the average of three determinations.
Fig. 3. Chromatographic puri¢cation of prelamin A endoprotease. A: Sephacryl S-200-HR chromatography: HeLa nuclear envelope extract
was prepared and concentrated as described under Section 2. A 200 Wl sample (1.068 mg of protein) was chromatographed on a Sepharose 200
column equilibrated in reaction bu¡er and eluted as described in Section 2. The protein content of each fraction (inset) was estimated from the
absorbance at 280 nm. An aliquot (20 Wl) of each fraction was assayed for prelamin A endoprotease activity. B: Mono S chromatography frac-
tions eluting between 74 and 104 min from S200 gel ¢ltration chromatography were pooled and concentrated to a volume of 4.5 ml (256 Wg of
protein) and applied to a Mono S 5/5 column equilibrated in 10 mM MES, 0.1% octyl glucoside, pH 5.0. The column was run at a £ow rate
of 0.75 ml/min and fractions were collected at 1 min intervals. The loading and NaCl gradient elution conditions were as described in Section
2. The protein content of each fraction was estimated from the absorbance at 280 nm (inset). An aliquot (20 Wl) of each fraction was assayed
for prelamin A endoprotease activity.
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chloride. This peak (s) from the Mono S column was col-
lected, concentrated and re-analyzed on a S200 gel ¢ltration
column. A peak of activity from this fraction was eluted
around 65 kDa (data not shown). SDS-PAGE of the fractions
that emerged from the ¢nal 0.3 M sodium chloride Mono S
column revealed two peptides with molecular masses of 68
and 65 kDa (Fig. 4).
In multiple preparations of endoprotease puri¢ed by the
above procedure, we always observed both 68 and 65 kDa
bands. Table 1 shows the results of one complete puri¢cation
procedure for prelamin A endoprotease using the steps out-
lined above. For consistency, we assayed all of the fractions
throughout the puri¢cation. The assay of crude nuclei ap-
peared to be inaccurate, since there was a large increase in
the total activity upon nuclear envelope preparation. The re-
sults indicated that endoprotease had been puri¢ed approxi-
mately 1200-fold relative to its activity in crude nuclei, with an
overall yield of 16.11%. With this procedure, after SDS-
PAGE, we were able to isolate approximately 5 Wg of puri¢ed
prelamin A endoprotease from 60 mg of HeLa crude nuclei
protein. It should be noted that the protein concentration of
the ¢nal puri¢ed material was estimated from the intensity of
the bands observed on Coomassie-stained SDS-PAGE (Fig. 4)
and is therefore, along with the ¢nal speci¢c activity, only
approximate.
Consistent with data that we have previously reported on
crude nuclei [14], the puri¢ed prelamin A endoprotease activ-
ity was inhibited greater than 95% by 1 mM concentrations of
serine protease inhibitors, aprotinin, PMSF and isocoumarin
(data not shown).
4. Discussion
Following farnesylation and the other two-canonical
CAAX box post-translational modi¢cations, prelamin A has
to undergo a further proteolytic cleavage to give rise to lamin
A. The functional signi¢cance of prelamin A endoproteolysis
in the formation and assembly of lamin A into the nuclear
lamina has been described previously by our laboratory and
others [10,16,17,20]. The further characterization of the func-
tional signi¢cance of prelamin A endoproteolytic processing
requires the e¡ective solubilization and puri¢cation of the
enzyme which catalyzes this reaction, the prelamin A endo-
protease. Our studies on subnuclear localization of the activity
indicate that it is associated with the nuclear envelope. The
enzyme is tightly associated with the nuclear envelope but can
be released, in the active form, by treatment of nuclear enve-
lope preparations with detergent. Previously, we showed that
prelamin A endoprotease activity is correlated with the level
of expression of prelamin A [16]. Now, in this study, its ac-
tivity is localized to the HeLa nuclear envelope. Since there is
no other farnesylated protein with the RSYLLG motif in
nuclei, it appears likely that prelamin A is the sole substrate
for the prelamin A endoprotease.
Solubilization of the enzyme could be demonstrated with
several detergents, although, for reasons stated above, octyl
glucoside was used in our studies. We have achieved some
success in partially purifying the prelamin A endoprotease
obtaining a preparation with an approximately 1200-fold
greater speci¢c activity than that of crude nuclei. The puri¢ed
material gave two bands on SDS-PAGE, the major band hav-
ing a molecular weight of 65 kDa, consistent with the size of
the enzyme as assessed by gel ¢ltration. We, therefore, pro-
pose that this polypeptide is the prelamin A endoprotease.
Based on inhibition of activity with aprotinin, PMSF and
isocoumarin, we conclude that the enzyme is a serine protease.
This is in contrast to the farnesylation-dependent endopro-
tease which catalyzes the maturation of the yeast a-factor, a
reaction similar to prelamin A endoproteolysis. The a-factor
endoprotease (Ste24p) appears to be a metalloprotease [21].
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